PerpEquitiesTop analysts on stock perps · Analyst
Chris Schott (J.P. Morgan): analyst track record on stock perps
Chris Schott of J.P. Morgan on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.3★
Success58%
Excess return+6.1%
rank#1,659
Ratings396
ratings on stock perps227
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 143 | 325 |
| Stock | 41 | 41 |
| Buy / hold / sell | 97 / 43 / 3 | 206 / 112 / 7 |
| Upgrades / downgrades / initiations | 1 / 1 / 0 | 6 / 2 / 1 |
| Price targets hit / missed | 37 / 86 (30%) | 109 / 160 (41%) |
| Avg. return after a rating (TipRanks) | -6.3% | +3.2% |
| Best / worst call | +39.8% / -63.6% | +230.5% / -68.3% |
After buy calls: median 21-day move +1.5% · vs S&P 500 -0.3% · targets hit within a year 62% (n = 218)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $LLY Eli Lilly and Company | Buy · Maintained | $1,400 | +24.7% | Sep 2, 2026 |
| $MRK Merck & Co., Inc. | Buy · Maintained | – | – | Aug 19, 2026 |
| $AMGN Amgen Inc. | Hold · Maintained | $350 | -8.5% | Aug 6, 2026 |
| $GILD Gilead Sciences, Inc. | Buy · Maintained | $160 | +10.5% | Aug 6, 2026 |
| $BMY Bristol Myers Squibb | Buy · Maintained | $73.00 | +14.5% | Aug 4, 2026 |
| $PFE Pfizer Inc. | Hold · Maintained | $28.00 | +1.3% | Aug 4, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Buy · Maintained | $900 | +13.5% | Aug 4, 2026 |
| $BIIB Biogen Inc. | Hold · Maintained | $210 | -2.5% | Jul 30, 2026 |
| $JNJ Johnson & Johnson | Hold · Reiterated | $270 | +1.4% | Jul 16, 2026 |
| $ABBV AbbVie Inc. | Buy · Reiterated | $280 | +9.8% | Jul 9, 2026 |
Recent ratings
- Sep 2, 2026 $LLY: Maintained · Buy · $1,400 · article
- Aug 19, 2026 $MRK: Maintained · Buy · article
- Aug 6, 2026 $MRK: Maintained · Buy · $150 · article
- Aug 6, 2026 $AMGN: Maintained · Hold · $350 · article
- Aug 6, 2026 $LLY: Reiterated · Buy · $1,400 · article
- Aug 6, 2026 $GILD: Maintained · Buy · $160 · article
- Aug 4, 2026 $BMY: Maintained · Buy · $73.00 · article
- Aug 4, 2026 $REGN: Maintained · Buy · $900 · article
- Aug 4, 2026 $PFE: Maintained · Hold · $28.00 · article
- Jul 30, 2026 $BIIB: Maintained · Hold · $210 · article
- Jul 31, 2026 $BMY: Reiterated · Buy · $73.00 · article
- Jul 22, 2026 $BIIB: Maintained · Hold · $185 · article
- Jul 16, 2026 $JNJ: Reiterated · Hold · $270 · article
- Jul 13, 2026 $MRK: Reiterated · Buy · $140 · article
- Jul 9, 2026 $GILD: Maintained · Buy · $160 · article
- Jul 9, 2026 $ABBV: Reiterated · Buy · $280 · article
- Jul 8, 2026 $PFE: Reiterated · Hold · $28.00 · article
- Jul 7, 2026 $JNJ: Maintained · Hold · $260 · article
- Jul 7, 2026 $LLY: Reiterated · Buy · $1,400 · article
- Jun 23, 2026 $PFE: Maintained · Hold · $30.00 · article
Chris Schott4.3★ · 58% success · +6.1% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.